Department of Biomedical Sciences and Technologies, University of Udine, p.le Kolbe 4, I-33100, Udine, Italy.
J Bioenerg Biomembr. 2010 Apr;42(2):117-23. doi: 10.1007/s10863-010-9270-2. Epub 2010 Feb 24.
Rat liver plasma membranes contain F(O)F(1) complexes (ecto-F(O)F(1)) displaying a similar molecular weight to the mitochondrial F(O)F(1) ATP synthase, as evidenced by Blue Native PAGE. Their ATPase activity was stably reduced in short-term extra-hepatic cholestasis. Immunoblotting and immunoprecipitation analyses demonstrated that the reduction in activity was not due to a decreased expression of ecto-F(O)F(1) complexes, but to an increased level of an inhibitory protein, ecto-IF(1), bound to ecto-F(O)F(1). Since cholestasis down regulates the hepatic uptake of HDL-cholesterol, and ecto-F(O)F(1) has been shown to mediate SR-BI-independent hepatic uptake of HDL-cholesterol, these findings provide support to the hypothesis that ecto-F(O)F(1) contributes to the fine control of reverse cholesterol transport, in parallel with SR-BI. No activity change of the mitochondrial F(O)F(1) ATP synthase (m-F(O)F(1)), or any variation of its association with m-IF(1) was observed in cholestasis, indicating that ecto-IF(1) expression level is modulated independently from that of ecto-F(O)F(1), m-IF(1) and m-F(O)F(1).
鼠肝质膜含有 F(O)F(1) 复合物(外质 F(O)F(1)),其分子量与线粒体 F(O)F(1) ATP 合酶相似,这一点通过 Blue Native PAGE 得到证实。在短期肝外胆汁淤积症中,其 ATP 酶活性稳定降低。免疫印迹和免疫沉淀分析表明,活性降低不是由于外质 F(O)F(1) 复合物表达减少,而是由于结合到外质 F(O)F(1)的抑制蛋白外质 IF(1)水平增加所致。由于胆汁淤积症下调了肝脏对 HDL-胆固醇的摄取,并且已经表明外质 F(O)F(1) 介导了 HDL-胆固醇的 SR-BI 非依赖性肝脏摄取,这些发现支持了这样一种假说,即外质 F(O)F(1) 与 SR-BI 一起参与了胆固醇逆转运的精细调控。在胆汁淤积症中,未观察到线粒体 F(O)F(1) ATP 合酶 (m-F(O)F(1)) 的活性变化,或其与 m-IF(1) 的任何变化,表明外质 IF(1) 的表达水平与外质 F(O)F(1)、m-IF(1) 和 m-F(O)F(1) 的表达水平独立调节。